Skip to content

Workspace: paxlovid_sotrovimab

This represents a working directory for Project: 91 - Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 on all of the secure environments supported by OpenSAFELY.

On each secure environment, the directory includes code from the repository, and the results of running it against real data (“jobs”). Researchers can request jobs are run from this page.

Workspace purpose

To evaluate the effectiveness of Paxlovid versus sotrovimab and molnupiravir in non-hospitalised COVID-19 patients at high risk of severe outcomes.